Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 3,744 shares at $70.69 ($266K) on 2021-09-03, disclosed to the SEC on 2021-09-03.
Open-market sale of $266k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.79 | 1,256 | $90K | 33.9% |
| 2 | $70.69 | 1,244 | $88K | 33.1% |
| 3 | $70.69 | 1,244 | $88K | 33.1% |
| Total | $71.06 avg | 3,744 | $266K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |